ASP Isotopes targets more than USD 300 million EBITDA by 2031 at investor presentation

Reuters2026/09/08 16:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ASP Isotopes outlined a multi-business execution plan spanning isotope enrichment, nuclear medicine, electronics materials, helium and LNG, nuclear fuels.
FY 2026 revenue forecast set above USD 14 million; Q2 2026 revenue reported at USD 5.1 million.
Cash and cash equivalents totaled USD 254.9 million as of June 30, 2026; workforce cited at more than 400 employees.
Helium milestone flagged as imminent; first production targeted before September 30, 2026; Phase 1 revenue run-rate projected near USD 27 million.
2031 EBITDA target set above USD 300 million; three enrichment plants in Pretoria described as operating across carbon-14, silicon-28, ytterbium-176.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ASP Isotopes targets more than USD 300 million EBITDA by 2031 at investor presentation

You may also like

Crypto prices